Skip to main content

ADVERTISEMENT

oncology management

04/06/2016
JCP Editors
New guidelines for non-small cell lung cancer (NSCLC) recommend testing for epidermal growth factor receptor (EGRF) mutations as a part of routine care for patients diagnosed with non-small cell lung cancer (NSCLC),...
New guidelines for non-small cell lung cancer (NSCLC) recommend testing for epidermal growth factor receptor (EGRF) mutations as a part of routine care for patients diagnosed with non-small cell lung cancer (NSCLC),...
New...
04/06/2016
Journal of Clinical Pathways
04/05/2016
JCP Editors
The National Comprehensive Cancer Network (NCCN) has announced three major changes to its guidelines for the treatment of multiple myeloma (MM) that broaden the population of patients eligible to start therapy,...
The National Comprehensive Cancer Network (NCCN) has announced three major changes to its guidelines for the treatment of multiple myeloma (MM) that broaden the population of patients eligible to start therapy,...
The...
04/05/2016
Journal of Clinical Pathways
Research in Review
04/04/2016
JCP Editors
Multidisciplinary care (MDC) facilitates the delivery of high-quality lung cancer services, improving survival, guideline-based treatment, and quality of life for patients with the disease, according to a new...
Multidisciplinary care (MDC) facilitates the delivery of high-quality lung cancer services, improving survival, guideline-based treatment, and quality of life for patients with the disease, according to a new...
...
04/04/2016
Journal of Clinical Pathways
Research in Review
04/04/2016
JCP Editors
The use of neoadjuvant chemoradiation for stage 2 and 3 rectal cancer is on the rise, but researchers are unsure whether this represents treatment innovation or greater disparity in cancer care. Currently, the...
The use of neoadjuvant chemoradiation for stage 2 and 3 rectal cancer is on the rise, but researchers are unsure whether this represents treatment innovation or greater disparity in cancer care. Currently, the...
The...
04/04/2016
Journal of Clinical Pathways
04/01/2016
JCP Editors
In a session at their 21st Annual Meeting in Hollywood, FL, National Comprehensive Cancer Network (NCCN) CEO Robert W Carlson, MD, discussed how NCCN Evidence Blocks stack up against other tools currently available...
In a session at their 21st Annual Meeting in Hollywood, FL, National Comprehensive Cancer Network (NCCN) CEO Robert W Carlson, MD, discussed how NCCN Evidence Blocks stack up against other tools currently available...
In a...
04/01/2016
Journal of Clinical Pathways
Research in Review
03/18/2016
JCP Editors
In its third annual State of Cancer Care in America report, the American Society of Clinical Oncology (ASCO) described a number of the advances and remaining challenges concerning cancer care—including the sudden...
In its third annual State of Cancer Care in America report, the American Society of Clinical Oncology (ASCO) described a number of the advances and remaining challenges concerning cancer care—including the sudden...
In its...
03/18/2016
Journal of Clinical Pathways
03/16/2016
JCP Editors
Active surveillance (AS) for patients with low-risk prostate cancer can provide similar quality of life to that of men living without cancer, according to a study presented at the European Association of Urology...
Active surveillance (AS) for patients with low-risk prostate cancer can provide similar quality of life to that of men living without cancer, according to a study presented at the European Association of Urology...
Active...
03/16/2016
Journal of Clinical Pathways
Research in Review
03/10/2016
JCP Editors
A study of prostate cancer has found that MRI (magnetic resource imaging) evaluations can influence clinical decision-making for both physicians and patients, though whether those decisions result in superior...
A study of prostate cancer has found that MRI (magnetic resource imaging) evaluations can influence clinical decision-making for both physicians and patients, though whether those decisions result in superior...
A...
03/10/2016
Journal of Clinical Pathways
Clinical Pathways GPS
03/08/2016
Discontinuation of treatment should be considered whenever treatment benefits are exceeded by their burden. When and how patients should be discontinued from treatment, however, may not necessarily be addressed by a...
Discontinuation of treatment should be considered whenever treatment benefits are exceeded by their burden. When and how patients should be discontinued from treatment, however, may not necessarily be addressed by a...
...
03/08/2016
Journal of Clinical Pathways
Research in Review
03/06/2016
JCP Editors
Patients with cancer and limited financial means are more likely to have a higher symptom burden and decreased quality of life (QOL), according to a recent study. Rising health care costs mean that the treatments...
Patients with cancer and limited financial means are more likely to have a higher symptom burden and decreased quality of life (QOL), according to a recent study. Rising health care costs mean that the treatments...
...
03/06/2016
Journal of Clinical Pathways